Arrhythmogenic right ventricular cardiomyopathy (ARVC): Cardiovascular magnetic resonance update

Journal of Cardiovascular Magnetic Resonance

Volumn 16, Issue 1, 2014, Pages

  Te Riele, Anneline S J M ^a,b   Tandri, Harikrishna ^b   Bluemke, David A ^b,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Cardiovascular magnetic resonance; Diagnosis; Genetics; Treatment

Indexed keywords

CONNECTIN; DESMIN; DESMOCOLLIN 2; DESMOGLEIN 2; DESMOPLAKIN; GADOLINIUM; LAMIN A; LAMIN C; PHOSPHOLAMBAN; PLAKOGLOBIN; PLAKOPHILIN 2; RYANODINE RECEPTOR; TRANSMEMBRANE PROTEIN 43; UNCLASSIFIED DRUG; GENETIC MARKER;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HEART DEPOLARIZATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; PATIENT CARE; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIOVERSION; DEATH, SUDDEN, CARDIAC; DEVICES; GENETIC MARKER; GENETIC PREDISPOSITION; HEART MUSCLE; HEART MUSCLE CONDUCTION SYSTEM; HEART RIGHT VENTRICLE FUNCTION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PREDICTIVE VALUE; RISK FACTOR; TREATMENT OUTCOME;

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HEART CONDUCTION SYSTEM; HUMANS; MAGNETIC RESONANCE IMAGING; MUTATION; MYOCARDIUM; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, RIGHT;

EID: 84906559446     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-014-0050-8     Document Type: Article

References (125)

1. Right ventricular dysplasia: a report of 24 adult cases. FI Marcus, GH Fontaine, G Guiraudon, R Frank, JL Laurenceau, C Malergue, Y Grosgogeat, Circulation 1982 65 384 398 7053899
2. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. D Corrado, G Thiene, A Nava, L Rossi, N Pennelli, Am J Med 1990 89 588 96 2239978
3. Arrhythmogenic right ventricular dysplasia a United States experience. D Dalal, K Nasir, C Bomma, K Prakasa, H Tandri, J Piccini, A Roguin, C Tichnell, C James, SD Russell, DP Judge, T Abraham, PJ Spevak, DA Bluemke, H Calkins, Circulation 2005 112 3823 32 16344387
4. Cardiovascular causes of sudden death in young individuals including athletes. C Basso, D Corrado, G Thiene, Cardiol Rev 1999 7 127 35 10423663
5. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. S Sen-Chowdhry, RD Morgan, JC Chambers, WJ McKenna, Annu Rev Med 2010 61 233 53 20059337
6. Arrhythmogenic right ventricular cardiomyopathy. C Basso, D Corrado, FI Marcus, A Nava, G Thiene, Lancet 2009 373 1289 300 19362677
7. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a review of molecular and clinical literature. B Murray, J Genet Couns 2012 21 494 504 22426942
8. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening. MG Cox, PA van der Zwaag, C van der Werf, JJ van der Smagt, M Noorman, ZA Bhuiyan, AC Wiesfeld, PG Volders, IM van Langen, DE Atsma, D Dooijes, A van den Wijngaard, AC Houweling, JD Jongbloed, L Jordaens, MJ Cramer, PA Doevendans, JM de Bakker, AA Wilde, JP van Tintelen, RN Hauer, Circulation 2011 123 2690 700 21606396
9. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. P Syrris, D Ward, A Asimaki, S Sen-Chowdhry, HY Ebrahim, A Evans, N Hitomi, M Norman, A Pantazis, AL Shaw, PM Elliott, WJ McKenna, Circulation 2006 113 356 64 16415378
10. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. I Rigato, B Bauce, A Rampazzo, A Zorzi, K Pilichou, E Mazzotti, F Migliore, MP Marra, A Lorenzon, M De Bortoli, M Calore, A Nava, L Daliento, D Gregori, S Iliceto, G Thiene, C Basso, D Corrado, Circ Cardiovasc Genet 2013 6 533 42 24070718
11. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family. PJ Kannankeril, ZA Bhuiyan, D Darbar, MM Mannens, AA Wilde, DM Roden, Heart Rhythm 2006 3 939 44 16876743
12. Radiology of the right ventricle. LM Boxt, Radiol Clin North Am 1999 37 379 400 10198649
13. Right ventricular cardiovascular magnetic resonance imaging: normal anatomy and spectrum of pathological findings. N Galea, I Carbone, D Cannata, G Cannavale, B Conti, R Galea, A Frustaci, C Catalano, M Francone, Insights Imaging 2013 4 213 23 23389464
14. Right ventricular arrhythmia: emergence of magnetic resonance imaging as an investigative tool. D Pennell, G Casolo, Eur Heart J 1997 18 1843 5 9447306
15. Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. A Jain, H Tandri, H Calkins, DA Bluemke, J Cardiovasc Magn Reson 2008 10 32 18570661
16. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. WJ McKenna, G Thiene, A Nava, F Fontaliran, C Blomstrom-Lundqvist, G Fontaine, F Camerini, Br Heart J 1994 71 215 8 8142187
17. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. MS Hamid, M Norman, A Quraishi, S Firoozi, R Thaman, JR Gimeno, B Sachdev, E Rowland, PM Elliott, WJ McKenna, J Am Coll Cardiol 2002 40 1445 50 12392835
18. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. K Nasir, C Bomma, H Tandri, A Roguin, D Dalal, K Prakasa, C Tichnell, C James, PJ Spevak, F Marcus, H Calkins, Circulation 2004 110 1527 34 15381658
19. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. B Bauce, C Basso, A Rampazzo, G Beffagna, L Daliento, G Frigo, S Malacrida, L Settimo, G Danieli, G Thiene, A Nava, Eur Heart J 2005 26 1666 75 15941723
20. Pathophysiology of arrhythmogenic cardiomyopathy. C Basso, B Bauce, D Corrado, G Thiene, Nat Rev Cardiol 2012 9 223 33
21. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia proposed modification of the task force criteria. FI Marcus, WJ McKenna, D Sherrill, C Basso, B Bauce, DA Bluemke, H Calkins, D Corrado, MG Cox, JP Daubert, G Fontaine, K Gear, R Hauer, A Nava, MH Picard, N Protonotarios, JE Saffitz, DM Sanborn, JS Steinberg, H Tandri, G Thiene, JA Towbin, A Tsatsopoulou, T Wichter, W Zareba, Circulation 2010 121 1533 41 20172911
22. Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: impact of new task force criteria. MG Cox, JJ van der Smagt, M Noorman, AC Wiesfeld, PG Volders, IM van Langen, DE Atsma, D Dooijes, AC Houweling, P Loh, L Jordaens, Y Arens, MJ Cramer, PA Doevendans, JP van Tintelen, AA Wilde, RN Hauer, Circ Arrhythm Electrophysiol 2010 3 126 33 20215590
23. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. G Quarta, A Muir, A Pantazis, P Syrris, K Gehmlich, P Garcia-Pavia, D Ward, S Sen-Chowdhry, PM Elliott, WJ McKenna, Circulation 2011 123 2701 9 21606390
24. Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations. N Protonotarios, A Anastasakis, L Antoniades, G Chlouverakis, P Syrris, C Basso, A Asimaki, A Theopistou, C Stefanadis, G Thiene, WJ McKenna, A Tsatsopoulou, Eur Heart J 2011 32 1097 104 21345848
25. Image quality assessment of the right ventricle with three different delayed enhancement sequences in patients suspected of ARVC/D. AS Plaisier, MC Burgmans, EP Vonken, NH Prakken, MG Cox, RN Hauer, BK Velthuis, MJ Cramer, Int J Cardiovasc Imaging 2012 28 595 601 21503703
26. Normal reference values for the adult right ventricle by magnetic resonance imaging. H Tandri, SK Daya, K Nasir, C Bomma, JA Lima, H Calkins, DA Bluemke, Am J Cardiol 2006 98 1660 4 17145230
27. ARVC: Imaging diagnosis is still in the eye of the beholder. DA Bluemke, J Am Coll Cardiol Img 2011 4 288 91
28. Impact of revised Task Force Criteria: distinguishing the athlete's heart from ARVC/D using cardiac magnetic resonance imaging. T Luijkx, BK Velthuis, NH Prakken, MG Cox, ML Bots, WP Mali, RN Hauer, MJ Cramer, Eur J Prev Cardiol 2012 19 885 91 21690305
29. Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. E Vermes, O Strohm, A Otmani, H Childs, H Duff, MG Friedrich, J Am Coll Cardiol Img 2011 4 282 7
30. Impact of new task force criteria in the diagnosis of arrhythmogenic right ventricular cardiomyopathy. G Femia, C Hsu, S Singarayar, RW Sy, M Kilborn, G Parker, M McGuire, C Semsarian, R Puranik, Int J Cardiol 2013 171 179 83 24342399
31. Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study. J Gomes, M Finlay, AK Ahmed, EJ Ciaccio, A Asimaki, JE Saffitz, G Quarta, M Nobles, P Syrris, S Chaubey, WJ McKenna, A Tinker, PD Lambiase, Eur Heart J 2012 33 1942 53 22240500
32. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. AS te Riele, A Bhonsale, CA James, N Rastegar, B Murray, JR Burt, C Tichnell, S Madhavan, DP Judge, DA Bluemke, SL Zimmerman, IR Kamel, H Calkins, H Tandri, J Am Coll Cardiol 2013 62 1761 9
33. Magnetic resonance imaging of right ventricular morphology and function in boxer dogs with arrhythmogenic right ventricular cardiomyopathy. RD Baumwart, KM Meurs, SV Raman, J Vet Intern Med 2009 23 271 4 19192154
34. Relation of cardiovascular risk factors to right ventricular structure and function as determined by magnetic resonance imaging (results from the multi-ethnic study of atherosclerosis). H Chahal, C Johnson, H Tandri, A Jain, WG Hundley, RG Barr, SM Kawut, JA Lima, DA Bluemke, Am J Cardiol 2010 106 110 6 20609657
35. Cardiac cine MRI: Quantification of the relationship between fast gradient echo and steady-state free precession for determination of myocardial mass and volumes. AA Malayeri, WC Johnson, R Macedo, J Bathon, JA Lima, DA Bluemke, J Magn Reson Imaging 2008 28 60 6 18581356
36. Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility. JC Moon, CH Lorenz, JM Francis, GC Smith, DJ Pennell, Radiology 2002 223 789 97 12034951
37. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. K Alfakih, S Plein, H Thiele, T Jones, JP Ridgway, MU Sivananthan, J Magn Reson Imaging 2003 17 323 9 12594722
38. Steady-state free precession magnetic resonance imaging of the heart: comparison with segmented k-space gradient-echo imaging. S Plein, TN Bloomer, JP Ridgway, TR Jones, GJ Bainbridge, MU Sivananthan, J Magn Reson Imaging 2001 14 230 6 11536399
39. MR assessment of left ventricular function: quantitative comparison of fast imaging employing steady-state acquisition (FIESTA) with fast gradient echo cine technique. W Li, JS Stern, VM Mai, LN Pierchala, RR Edelman, PV Prasad, J Magn Reson Imaging 2002 16 559 64 12412033
40. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. J Barkhausen, SG Ruehm, M Goyen, T Buck, G Laub, JF Debatin, Radiology 2001 219 264 9 11274568
41. Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. AM Maceira, SK Prasad, M Khan, DJ Pennell, Eur Heart J 2006 27 2879 88 17088316
42. Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. H Tandri, H Calkins, K Nasir, C Bomma, E Castillo, J Rutberg, C Tichnell, JA Lima, DA Bluemke, J Cardiovasc Electrophysiol 2003 14 476 82 12776863
43. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. H Tandri, R Macedo, H Calkins, F Marcus, D Cannom, M Scheinman, J Daubert, M Estes 3rd, D Wilber, M Talajic, H Duff, A Krahn, M Sweeney, H Garan, DA Bluemke, Am Heart J 2008 155 147 53 18082506
44. MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. DA Bluemke, EA Krupinski, T Ovitt, K Gear, E Unger, L Axel, LM Boxt, G Casolo, VA Ferrari, B Funaki, S Globits, CB Higgins, P Julsrud, M Lipton, J Mawson, A Nygren, DJ Pennell, A Stillman, RD White, T Wichter, F Marcus, Cardiology 2003 99 153 62 12824723
45. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. D Dalal, H Tandri, DP Judge, N Amat, R Macedo, R Jain, C Tichnell, A Daly, C James, SD Russell, T Abraham, DA Bluemke, H Calkins, J Am Coll Cardiol 2009 53 1289 99 19358943
46. The "accordion sign," a new tune in arrhythmogenic right ventricular dysplasia/cardiomyopathy magnetic resonance imaging? M Groenink, AA Wilde, J Am Coll Cardiol 2009 53 1300 1 19358944
47. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? C Basso, G Thiene, D Corrado, A Angelini, A Nava, M Valente, Circulation 1996 94 983 91 8790036
48. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. FE Marchlinski, E Zado, S Dixit, E Gerstenfeld, DJ Callans, H Hsia, D Lin, H Nayak, A Russo, W Pulliam, Circulation 2004 110 2293 8 15477406
49. Regional differences in systolic and diastolic function in arrhythmogenic right ventricular dysplasia/cardiomyopathy using magnetic resonance imaging. C Bomma, D Dalal, H Tandri, K Prakasa, K Nasir, A Roguin, C Tichnell, C James, JA Lima, H Calkins, DA Bluemke, Am J Cardiol 2005 95 1507 11 15950585
50. Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. MP Marra, L Leoni, B Bauce, F Corbetti, A Zorzi, F Migliore, M Silvano, I Rigato, F Tona, G Tarantini, L Cacciavillani, C Basso, G Buja, G Thiene, S Iliceto, D Corrado, Circ Arrhythm Electrophysiol 2012 5 91 100 22139887
51. Early detection of regional functional abnormalities in asymptomatic ARVD/C gene carriers. AJ Teske, MG Cox, AS Te Riele, BW De Boeck, PA Doevendans, RN Hauer, MJ Cramer, J Am Soc Echocardiogr 2012 25 997 1006 22727198
52. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. FC Garcia, V Bazan, ES Zado, JF Ren, FE Marchlinski, Circulation 2009 120 366 75 19620503
53. Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. D Corrado, C Basso, L Leoni, B Tokajuk, P Turrini, B Bauce, F Migliore, A Pavei, G Tarantini, M Napodano, A Ramondo, G Buja, S Iliceto, G Thiene, J Am Coll Cardiol 2008 51 731 9 18279737
54. Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced. AS Te Riele, CA James, B Philips, N Rastegar, A Bhonsale, JA Groeneweg, B Murray, C Tichnell, DP Judge, MJ Cramer, BK Velthuis, DA Bluemke, SL Zimmerman, IR Kamel, RN Hauer, H Calkins, H Tandri, J Cardiovasc Electrophysiol 2013 24 1311 20
55. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. S Sen-Chowdhry, P Syrris, D Ward, A Asimaki, E Sevdalis, WJ McKenna, Circulation 2007 115 1710 20 17372169
56. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathyysplasia: a multicenter study. D Corrado, C Basso, G Thiene, WJ McKenna, MJ Davies, F Fontaliran, A Nava, F Silvestri, C Blomstrom-Lundqvist, EK Wlodarska, G Fontaine, F Camerini, cardiomyopathy/dysplasia 1997 30 1512 20
57. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. S Sen-Chowdhry, P Syrris, SK Prasad, SE Hughes, R Merrifield, D Ward, DJ Pennell, WJ McKenna, J Am Coll Cardiol 2008 52 2175 87 19095136
58. Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy-a scintigraphic and echocardiographic study. L Lindstrom, E Nylander, H Larsson, B Wranne, Clin Physiol Funct Imaging 2005 25 171 7 15888098
59. Prevalence of left ventricular regional dysfunction in arrhythmogenic right ventricular dysplasia: a tagged MRI study. A Jain, ML Shehata, M Stuber, SJ Berkowitz, H Calkins, JA Lima, DA Bluemke, H Tandri, Circ Cardiovasc Imaging 2010 3 290 7 20197508
60. Arrhythmogenic cardiomyopathy. Patterns of ventricular involvement using cardiac magnetic resonance. B Igual, E Zorio, A Maceira, J Estornell, MP Lopez-Lereu, JV Monmeneu, A Quesada, J Navarro, F Mas, A Salvador, Rev Esp Cardiol 2011 64 1114 22
61. Incidence of Non-Task Force Criteria Findings by CMR in Subjects with Various Arrhythmogenic Right Ventricular Cardiomyopathy Scores. N Rastegar, SL Zimmerman, CA James, B Murray, AS te Riele, A Bhonsale, C Tichnell, H Calkins, H Tandri, DA Bluemke, IR Kamel, Radiol Soc North Am (RSNA) 2013 SE04-05. Abstract
62. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. SC Vasaiwala, C Finn, J Delpriore, F Leya, J Gagermeier, JG Akar, P Santucci, K Dajani, D Bova, MM Picken, C Basso, F Marcus, DJ Wilber, J Cardiovasc Electrophysiol 2009 20 473 6 19017339
63. High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy. M Pieroni, A Dello Russo, F Marzo, G Pelargonio, M Casella, F Bellocci, F Crea, J Am Coll Cardiol 2009 53 681 9 19232901
64. Cardiovascular magnetic resonance in cardiac amyloidosis. AM Maceira, J Joshi, SK Prasad, JC Moon, E Perugini, I Harding, MN Sheppard, PA Poole-Wilson, PN Hawkins, DJ Pennell, Circulation 2005 111 186 93 15630027
65. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. RG Assomull, SK Prasad, J Lyne, G Smith, ED Burman, M Khan, MN Sheppard, PA Poole-Wilson, DJ Pennell, J Am Coll Cardiol 2006 48 1977 85 17112987
66. Utility of myocardial fibrosis and fatty infiltration detected by cardiac magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular dysplasia-a single centre experience. HB Pfluger, A Phrommintikul, JA Mariani, JG Cherayath, AJ Taylor, Heart Lung Circ 2008 17 478 83 18538631
67. Late enhancement: a new feature in MRI of arrhythmogenic right ventricular cardiomyopathy? P Hunold, H Wieneke, O Bruder, U Krueger, T Schlosser, R Erbel, J Barkhausen, J Cardiovasc Magn Reson 2005 7 649 55 16136854
68. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. H Tandri, M Saranathan, ER Rodriguez, C Martinez, C Bomma, K Nasir, B Rosen, JA Lima, H Calkins, DA Bluemke, J Am Coll Cardiol 2005 45 98 103 15629382
69. Noninvasive diagnosis of electroanatomic abnormalities in arrhythmogenic right ventricular cardiomyopathy. P Santangeli, M Pieroni, A Dello Russo, M Casella, G Pelargonio, A Macchione, A Camporeale, C Smaldone, S Bartoletti, L Di Biase, F Bellocci, A Natale, Circ Arrhythm Electrophysiol 2010 3 632 8 20937720
70. Imaging of scar in patients with ventricular arrhythmias of right ventricular origin: cardiac magnetic resonance versus electroanatomic mapping. P Santangeli, C Hamilton-Craig, A Dello Russo, M Pieroni, M Casella, G Pelargonio, L Di Biase, C Smaldone, S Bartoletti, ML Narducci, C Tondo, F Bellocci, A Natale, J Cardiovasc Electrophysiol 2011 22 1359 66 21736658
71. Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. C Bomma, J Rutberg, H Tandri, K Nasir, A Roguin, C Tichnell, R Rodriguez, C James, E Kasper, P Spevak, DA Bluemke, H Calkins, J Cardiovasc Electrophysiol 2004 15 300 6 15030420
72. Utility of cardiac magnetic resonance in the evaluation of unselected patients with possible arrhythmogenic right ventricular cardiomyopathy. KL Looi, C Edwards, H Hart, JP Christiansen, Clin Med Insights Cardiol 2012 6 153 62 23226076
73. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. H Tandri, E Castillo, VA Ferrari, K Nasir, D Dalal, C Bomma, H Calkins, DA Bluemke, J Am Coll Cardiol 2006 48 2277 84 17161260
74. Marked lipomatous infiltration of the right ventricle: MRI findings in relation to arrhythmogenic right ventricular dysplasia. R Macedo, K Prakasa, C Tichnell, F Marcus, H Calkins, JA Lima, DA Bluemke, AJR Am J Roentgenol 2007 188 423 7 17449737
75. Pectus excavatum: echocardiography and cardiac MRI reveal frequent pericardial effusion and right-sided heart anomalies. S Oezcan, CH Attenhofer Jost, M Pfyffer, C Kellenberger, R Jenni, C Binggeli, A Faeh-Gunz, B Seifert, C Scharf, O Kretschmar, ER Valsangiacomo Buechel, Eur Heart J Cardiovasc Imaging 2012 13 673 9 22298154
76. Right ventricular wall motion abnormalities found in healthy subjects by cardiovascular magnetic resonance imaging and characterized with a new segmental model. B Sievers, M Addo, U Franken, HJ Trappe, J Cardiovasc Magn Reson 2004 6 601 8 15347124
77. Pitfalls in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. F Marcus, C Basso, K Gear, VL Sorrell, Am J Cardiol 2010 105 1036 9 20346327
78. Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy. DA Steckman, PM Schneider, JL Schuller, RG Aleong, DT Nguyen, G Sinagra, G Vitrella, F Brun, MA Cova, L Pagnan, L Mestroni, PD Varosy, WH Sauer, Am J Cardiol 2012 110 575 9 22595349
79. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. LT Cooper, KL Baughman, AM Feldman, A Frustaci, M Jessup, U Kuhl, GN Levine, J Narula, RC Starling, J Towbin, R Virmani, J Am Coll Cardiol 2007 50 1914 31 17980265
80. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). G McKoy, N Protonotarios, A Crosby, A Tsatsopoulou, A Anastasakis, A Coonar, M Norman, C Baboonian, S Jeffery, WJ McKenna, Lancet 2000 355 2119 24 10902626
81. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. K Pilichou, A Nava, C Basso, G Beffagna, B Bauce, A Lorenzon, G Frigo, A Vettori, M Valente, J Towbin, G Thiene, GA Danieli, A Rampazzo, Circulation 2006 113 1171 9 16505173
82. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. A Rampazzo, A Nava, S Malacrida, G Beffagna, B Bauce, V Rossi, R Zimbello, B Simionati, C Basso, G Thiene, JA Towbin, GA Danieli, Am J Hum Genet 2002 71 1200 6 12373648
83. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. B Gerull, A Heuser, T Wichter, M Paul, CT Basson, DA McDermott, BB Lerman, SM Markowitz, PT Ellinor, CA MacRae, S Peters, KS Grossmann, J Drenckhahn, B Michely, S Sasse-Klaassen, W Birchmeier, R Dietz, G Breithardt, E Schulze-Bahr, L Thierfelder, Nat Genet 2004 36 1162 4 15489853
84. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. P Syrris, D Ward, A Evans, A Asimaki, E Gandjbakhch, S Sen-Chowdhry, WJ McKenna, Am J Hum Genet 2006 79 978 84 17033975
85. Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. AD den Haan, BY Tan, MN Zikusoka, LI Llado, R Jain, A Daly, C Tichnell, C James, N Amat-Alarcon, T Abraham, SD Russell, DA Bluemke, H Calkins, D Dalal, DP Judge, Circ Cardiovasc Genet 2009 2 428 35
86. Impact of Genotype on Clinical Course in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated Mutation Carriers. A Bhonsale, JA Groeneweg, CA James, D Dooijes, C Tichnell, JD Jongbloed, B Murray, JF van der Heijden, H Tandri, AA Wilde, D Judge, JP van Tintelen, H Calkins, RN Hauer, Circulation 2012 126 13208
87. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. JP van Tintelen, MM Entius, ZA Bhuiyan, R Jongbloed, AC Wiesfeld, AA Wilde, J van der Smagt, LG Boven, MM Mannens, IM van Langen, RM Hofstra, LC Otterspoor, PA Doevendans, LM Rodriguez, IC van Gelder, RN Hauer, Circulation 2006 113 1650 8 16567567
88. The cardiac desmosome and arrhythmogenic cardiomyopathies: from gene to disease. M Delmar, WJ McKenna, Circ Res 2010 107 700 14 20847325
89. Desmosome-ion channel interactions and their possible role in arrhythmogenic cardiomyopathy. M Delmar, Pediatr Cardiol 2012 33 975 9 22407454
90. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). SR Kaplan, JJ Gard, N Protonotarios, A Tsatsopoulou, C Spiliopoulou, A Anastasakis, CP Squarcioni, WJ McKenna, G Thiene, C Basso, N Brousse, G Fontaine, JE Saffitz, Heart Rhythm 2004 1 3 11 15851108
91. Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. PY Sato, H Musa, W Coombs, G Guerrero-Serna, GA Patino, SM Taffet, LL Isom, M Delmar, Circ Res 2009 105 523 6 19661460
92. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). N Tiso, DA Stephan, A Nava, A Bagattin, JM Devaney, F Stanchi, G Larderet, B Brahmbhatt, K Brown, B Bauce, M Muriago, C Basso, G Thiene, GA Danieli, A Rampazzo, Hum Mol Genet 2001 10 189 94 11159936
93. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. G Beffagna, G Occhi, A Nava, L Vitiello, A Ditadi, C Basso, B Bauce, G Carraro, G Thiene, JA Towbin, GA Danieli, A Rampazzo, Cardiovasc Res 2005 65 366 73 15639475
94. Recurrent and founder mutations in the Netherlands: Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia. PA van der Zwaag, MG Cox, C van der Werf, AC Wiesfeld, JD Jongbloed, D Dooijes, H Bikker, R Jongbloed, AJ Suurmeijer, MP van den Berg, RM Hofstra, RN Hauer, AA Wilde, JP van Tintelen, Neth Heart J 2010 18 583 91
95. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. ND Merner, KA Hodgkinson, AF Haywood, S Connors, VM French, JD Drenckhahn, C Kupprion, K Ramadanova, L Thierfelder, W McKenna, B Gallagher, L Morris-Larkin, AS Bassett, PS Parfrey, TL Young, Am J Hum Genet 2008 82 809 21 18313022
96. Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. JP van Tintelen, IC Van Gelder, A Asimaki, AJ Suurmeijer, AC Wiesfeld, JD Jongbloed, A van den Wijngaard, JB Kuks, KY van Spaendonck-Zwarts, N Notermans, L Boven, F van den Heuvel, HE Veenstra-Knol, JE Saffitz, RM Hofstra, MP van den Berg, Heart Rhythm 2009 6 1574 83 19879535
97. Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. M Taylor, S Graw, G Sinagra, C Barnes, D Slavov, F Brun, B Pinamonti, EE Salcedo, W Sauer, S Pyxaras, B Anderson, B Simon, J Bogomolovas, S Labeit, H Granzier, L Mestroni, Circulation 2011 124 876 85 21810661
98. Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype? JA Groeneweg, PA van der Zwaag, JD Jongbloed, MG Cox, A Vreeker, RA de Boer, JF van der Heijden, TA van Veen, WJ McKenna, JP van Tintelen, D Dooijes, RN Hauer, Heart Rhythm 2013 10 548 59 23270881
99. Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy. MM DeWitt, HM MacLeod, B Soliven, EM McNally, J Am Coll Cardiol 2006 48 1396 8 17010801
100. Truncations of titin causing dilated cardiomyopathy. DS Herman, L Lam, MR Taylor, L Wang, P Teekakirikul, D Christodoulou, L Conner, SR DePalma, B McDonough, E Sparks, DL Teodorescu, AL Cirino, NR Banner, DJ Pennell, S Graw, M Merlo, A Di Lenarda, G Sinagra, JM Bos, MJ Ackerman, RN Mitchell, CE Murry, NK Lakdawala, CY Ho, PJ Barton, SA Cook, L Mestroni, JG Seidman, CE Seidman, N Engl J Med 2012 366 619 28 22335739
101. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. G Quarta, P Syrris, M Ashworth, S Jenkins, K Zuborne Alapi, J Morgan, A Muir, A Pantazis, WJ McKenna, PM Elliott, Eur Heart J 2012 33 1128 36 22199124
102. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. PA van der Zwaag, IA van Rijsingen, A Asimaki, JD Jongbloed, DJ van Veldhuisen, AC Wiesfeld, MG Cox, LT van Lochem, RA de Boer, RM Hofstra, I Christiaans, KY van Spaendonck-Zwarts, L d Deprez RH, DP Judge, H Calkins, AJ Suurmeijer, RN Hauer, JE Saffitz, AA Wilde, MP van den Berg, JP van Tintelen, Eur J Heart Fail 2012 14 1199 207 22820313
103. Chronic right-sided myocarditis mimicking arrhythmogenic right ventricular dysplasia. PJ Michaels, JA Kobashigawa, JS Child, MC Fishbein, Hum Pathol 2000 31 618 21 10836303
104. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. MG Friedrich, U Sechtem, J Schulz-Menger, G Holmvang, P Alakija, LT Cooper, JA White, H Abdel-Aty, M Gutberlet, S Prasad, A Aletras, JP Laissy, I Paterson, NG Filipchuk, A Kumar, M Pauschinger, P Liu, J Am Coll Cardiol 2009 53 1475 87 19389557
105. MRI detection of myocardial perfusion changes by gadolinium-DTPA infusion during dipyridamole hyperemia. DD Miller, G Holmvang, JB Gill, D Dragotakes, HL Kantor, RD Okada, TJ Brady, Magn Reson Med 1989 10 246 55 2761383
106. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. MJ Ackerman, SG Priori, S Willems, C Berul, R Brugada, H Calkins, AJ Camm, PT Ellinor, M Gollob, R Hamilton, RE Hershberger, DP Judge, H Le Marec, WJ McKenna, E Schulze-Bahr, C Semsarian, JA Towbin, H Watkins, A Wilde, C Wolpert, DP Zipes, Heart Rhythm 2011 8 1308 39 21787999
107. Arrhythmogenic right ventricular cardiomyopathy: a paradigm of overlapping disorders. JA Towbin, Ann Noninvasive Electrocardiol 2008 13 325 6 18973488
108. Genetics and cardiovascular disease: a policy statement from the American Heart Association. EA Ashley, RE Hershberger, C Caleshu, PT Ellinor, JG Garcia, DM Herrington, CY Ho, JA Johnson, SJ Kittner, CA Macrae, G Mudd-Martin, DJ Rader, DM Roden, D Scholes, FW Sellke, JA Towbin, J Van Eyk, BB Worrall, Circulation 2012 126 142 57 22645291
109. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. P Charron, M Arad, E Arbustini, C Basso, Z Bilinska, P Elliott, T Helio, A Keren, WJ McKenna, L Monserrat, S Pankuweit, A Perrot, C Rapezzi, A Ristic, H Seggewiss, I van Langen, L Tavazzi, D Pericardial, Eur Heart J 2010 31 2715 26 20823110
110. Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies. S Sen-Chowdhry, P Syrris, WJ McKenna, Eur Heart J 2005 26 1582 4 15941722
111. Genotype-specific pattern of LV involvement in ARVD/C. AS Te Riele, A Bhonsale, JR Burt, SL Zimmerman, H Tandri, J Am Coll Cardiol Img 2012 5 849 51
112. Does sports activity enhance the risk of sudden death in adolescents and young adults? D Corrado, C Basso, G Rizzoli, M Schiavon, G Thiene, J Am Coll Cardiol 2003 42 1959 63 14662259
113. Exercise Increases Age-Related Penetrance and Arrhythmic Risk in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated Desmosomal Mutation Carriers. CA James, A Bhonsale, C Tichnell, B Murray, SD Russell, H Tandri, RJ Tedford, DP Judge, H Calkins, J Am Coll Cardiol 2013 62 1290 7 23871885
114. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. T Wichter, M Paul, C Wollmann, T Acil, P Gerdes, O Ashraf, TD Tjan, R Soeparwata, M Block, M Borggrefe, HH Scheld, G Breithardt, D Bocker, Circulation 2004 109 1503 8 15007002
115. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. D Corrado, H Calkins, MS Link, L Leoni, S Favale, M Bevilacqua, C Basso, D Ward, G Boriani, R Ricci, JP Piccini, D Dalal, M Santini, G Buja, S Iliceto, NA 3rd Estes, T Wichter, WJ McKenna, G Thiene, FI Marcus, Circulation 2010 122 1144 52 20823389
116. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. JP Piccini, D Dalal, A Roguin, C Bomma, A Cheng, K Prakasa, J Dong, C Tichnell, C James, S Russell, J Crosson, RD Berger, JE Marine, G Tomaselli, H Calkins, Heart Rhythm 2005 2 1188 94 16253908
117. Arrhythmogenic right ventricular cardiomyopathy: diagnostic and prognostic value of the cardiac MRI in relation to arrhythmia-free survival. DI Keller, S Osswald, J Bremerich, G Bongartz, TA Cron, P Hilti, ME Pfisterer, PT Buser, Int J Cardiovasc Imaging 2003 19 537 43 discussion 545-537 14690194
118. Prognostic value of cardiovascular magnetic resonance in patients with suspected arrhythmogenic right ventricular cardiomyopathy. M Deac, F Alpendurada, F Fanaie, R Vimal, JP Carpenter, A Dawson, C Miller, I Roussin, E di Pietro, TF Ismail, M Roughton, J Wong, D Dawson, JA Till, MN Sheppard, RH Mohiaddin, PJ Kilner, DJ Pennell, SK Prasad, Int J Cardiol 2013 168 3514 21 23701935
119. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. T Wichter, M Borggrefe, W Haverkamp, X Chen, G Breithardt, Circulation 1992 86 29 37 1617780
120. Multidisciplinary Study of Right Ventricular Dysplasia I. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. GM Marcus, DV Glidden, B Polonsky, W Zareba, LM Smith, DS Cannom, NA Estes 3rd, F Marcus, MM Scheinman, J Am Coll Cardiol 2009 54 609 15 19660690
121. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. D Dalal, R Jain, H Tandri, J Dong, SM Eid, K Prakasa, C Tichnell, C James, T Abraham, SD Russell, S Sinha, DP Judge, DA Bluemke, JE Marine, H Calkins, J Am Coll Cardiol 2007 50 432 40 17662396
122. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. B Philips, S Madhavan, C James, C Tichnell, B Murray, D Dalal, A Bhonsale, S Nazarian, DP Judge, SD Russell, T Abraham, H Calkins, H Tandri, Circ Arrhythm Electrophysiol 2012 5 499 505 22492430
123. Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation? B Schmidt, KR Chun, D Baensch, M Antz, B Koektuerk, RR Tilz, A Metzner, F Ouyang, KH Kuck, Heart Rhythm 2010 7 1746 52 20709191
124. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. R Bai, L Di Biase, K Shivkumar, P Mohanty, R Tung, P Santangeli, LC Saenz, M Vacca, A Verma, Y Khaykin, S Mohanty, JD Burkhardt, R Hongo, S Beheiry, A Dello Russo, M Casella, G Pelargonio, P Santarelli, J Sanchez, C Tondo, A Natale, Circ Arrhythm Electrophysiol 2011 4 478 85 21665983
125. Usefulness of contrast-enhanced cardiac magnetic resonance in identifying the ventricular arrhythmia substrate and the approach needed for ablation. D Andreu, JT Ortiz-Perez, T Boussy, J Fernandez-Armenta, TM de Caralt, RJ Perea, S Prat-Gonzalez, L Mont, J Brugada, A Berruezo, Eur Heart J 2014 35 1316 26 24394378